AI Robotics in Medicine
PublicTracking updates in AI Robotics in the healthcare industry
Hyderabad Telesurgery From Wuhan Signals Remote Care's Next Phase
Saturday, May 30, 2026
Clinical technology is crossing distance and disciplines: a 90-minute, robotics-assisted ureteric reimplantation in Hyderabad was performed remotely by a urologist 3,900 km away in Wuhan, underscoring efforts to extend advanced surgery beyond major cities.
That momentum meets the realities of workforce and governance—PM&R faculty pathways now stress ABPMR certification, fellowships, and publishable work in neurorehabilitation and robotics, while Canada readies a national AI strategy and Tempus opens its foundation models to researchers amid calls for robust oversight.
Watch whether standards for telesurgery and training keep pace with rapid adoption, and how bioelectronic medicine—buoyed by a 2025 FDA approval for a vagus nerve stimulator and growth forecasts through 2034—shapes clinical practice and market growth.
Tracking: Medicine Robotics · AI Medicine · AI Healthcare
Geography: United States, European Union, United Kingdom, Germany, France, Switzerland, Israel, China, Japan, South Korea, Singapore, India, Canada, Australia, San Francisco Bay Area, Boston/Cambridge (MA), Pittsburgh, Houston, London, Cambridge (UK), Berlin, Paris, Tel Aviv, Shanghai, Shenzhen, Beijing, Tokyo, Seoul, Singapore (city), Bangalore, Toronto, Montreal
1. Hyderabad patient operated on remotely by urologist 3,900 km away in Wuhan
A 57-year-old Hyderabad woman underwent a robotics-assisted tele-surgery for ureteric obstruction, performed by Indian urologist Dr Syed Mohammad Ghouse while he was in Wuhan, China.
The ureteric reimplantation lasted 90 minutes and was completed successfully, PTI reported. A human aide stood by the patient in the operating room to communicate with Wuhan and assist during any emergency.
Ghouse said four to five other surgeons at the Wuhan conference also performed telesurgeries to their home countries.
The case follows Dr Mohit Bhandari’s July 2025 procedure from Strasbourg to Indore, which PTI reported as the world’s first transcontinental bariatric surgery. Proponents argue robotic surgery can extend advanced care beyond major cities.
Key facts:
- 57-year-old woman in Hyderabad treated for ureteric obstruction.
- Dr Syed Mohammad Ghouse operated remotely from Wuhan, 3,900 km away.
- Procedure: ureteric reimplantation via robotics-assisted tele-surgery.
- Surgery lasted 90 minutes and was successful, per PTI.
- Human aide was present beside the patient for communication and emergencies.
Why it matters: Cross-border, real-time telesurgery moves remote care from concept to clinical reality, suggesting specialists can treat patients without travel.
That could expand access to advanced urologic and other procedures in smaller cities and rural areas, where expertise is scarce. Hospitals could leverage visiting experts more flexibly, while patients avoid costly referrals.
However, scale-up will hinge on robust connectivity, trained bedside teams, and clear protocols for safety and handoffs. Regulators and payers will also need to clarify credentialing, liability, data handling, and reimbursement for remote operations.
Watch for multicenter demonstrations across specialties, standardized teleoperation playbooks, and early reimbursement pilots.
2. How to Build a PM&R Faculty Career: Training and Research Benchmarks
A new guide maps how to become faculty in Physical Medicine and Rehabilitation (PM&R), a specialty restoring function after stroke, spinal cord injury, sports injuries, and surgery.
It describes faculty roles that blend patient care, teaching, and research on neuroplasticity and robotic prosthetics at institutions such as Mayo Clinic and Spaulding Rehabilitation Hospital.
The pathway begins with an MD or DO after undergraduate study, followed by a preliminary internship and PM&R residency. Requirements for faculty competitiveness include ABPMR certification, frequent fellowship training of 1–2 years, and scholarship.
The article also recommends building 1,000+ clinical hours in stroke or spinal units, publishing 5+ peer‑reviewed papers in neurorehabilitation or robotics, and networking at AAPM&R conferences.
It presents conflicting residency structures—three years after an internship versus a four‑year accredited residency—signaling program‑specific variation applicants must verify.
Key facts:
- Securing faculty roles requires ABPMR board certification after accredited PM&R training.
- The article cites both three- and four-year PM&R residency structures.
- Targets include 1,000+ clinical hours and 5+ peer-reviewed neurorehab or robotics papers.
Why it matters: Clear, quantified milestones help trainees plan timelines, prioritize research in neuroplasticity and robotics, and position for competitive faculty posts.
Programs and departments can use these signals to standardize expectations and recruit candidates aligned with clinical and research priorities.
The residency-length ambiguity underscores the need for applicants to confirm structure and prerequisites with each program and align fellowship choices to subspecialty goals.
3. Canada to unveil AI strategy; Tempus opens models to researchers
Canadian Prime Minister Mark Carney told Pope Leo XIV that Canada aims to lead on responsible AI and said the federal government will release a national AI strategy next week.
Their discussion followed the Pope’s recent document calling for robust AI regulation, which Carney welcomed. Separately, Tempus launched the PRECISION Challenge, a national program opening its foundation model work to the broader research community.
In parallel, bioelectronic medicine continues to gain traction, with a market report highlighting a 2025 FDA approval of SetPoint Medical’s vagus nerve stimulator for rheumatoid arthritis and projecting strong growth through 2034.
Key facts:
- May 29, 2026: Carney told Pope Leo XIV Canada seeks responsible AI leadership.
- Tempus launched the PRECISION Challenge to open its foundation model work nationally.
- July 2025: SetPoint Medical won FDA approval for a rheumatoid arthritis neurostimulation device.
Why it matters: Policy signals from Canada and the Vatican align with a push for responsible AI, shaping how hospitals and vendors deploy clinical models.
Tempus’s move to open its foundation model work could speed validation and real-world evidence generation by academic and clinical partners.
On the device side, FDA’s 2025 approval in rheumatoid arthritis and a bullish market outlook suggest momentum for non-pharmacologic, AI-enabled neuromodulation.
Watch for the contents of Canada’s AI strategy, how widely researchers engage with Tempus’s program, and whether reimbursement and clinical guidelines keep pace with bioelectronic therapies.